Alphamab Oncology (HKG:9966)
Hong Kong · Delayed Price · Currency is HKD 7.58
+0.02 (0.26%)
Jul 30, 2026, 4:08 PM HKT
Alphamab Oncology Market Cap
Alphamab Oncology has a market cap or net worth of 7.32 billion as of July 29, 2026. Its market cap has decreased by -21.14% in one year.
Market Cap
7.32B
Enterprise Value
5.96B
Revenue
630.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.58
ChartMarket Cap Chart
Since December 12, 2019, Alphamab Oncology's market cap has decreased from 12.11B to 7.32B, a decrease of -39.54%. That is a compound annual growth rate of -7.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 7.32B | -22.86% |
| Dec 31, 2025 | 9.49B | 181.80% |
| Dec 31, 2024 | 3.37B | -47.42% |
| Dec 29, 2023 | 6.41B | -36.87% |
| Dec 30, 2022 | 10.15B | -20.36% |
| Dec 31, 2021 | 12.74B | -16.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shaanxi Micot Pharmaceutical Technology | 9.34B |
| Everest Medicines | 8.79B |
| TenNor Therapeutics (Suzhou) | 8.57B |
| Lepu Biopharma | 8.16B |
| Suzhou Ribo Life Science | 7.89B |
| CARsgen Therapeutics Holdings | 7.84B |
| Shanghai Haohai Biological Technology | 7.37B |
| Abbisko Cayman | 7.11B |